Immersive Virtual Reality Meditation in Voice Therapy

NCT ID: NCT07176013

Last Updated: 2026-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-03

Study Completion Date

2026-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to explore the feasibility of incorporating regular guided meditations via immersive virtual reality (IVR) at the start of voice therapy sessions to facilitate better learning and retention of treatment. The study will involve 30 participants, and use the TRIPP application with the Meta Quest 2 virtual reality headset, known for its immersive meditation experiences designed to calm or focus the user. The objective is to investigate the immediate effects of meditation/mindfulness in IVR on vocal production, with the goal of improving self-regulation, attentional focus, and reducing vocal hyperfunction. IVR has been utilized in mental health settings and exposure therapy for various conditions, but its application in voice therapy, particularly for anxiety reduction through fully immersive meditation, remains unexplored. The study seeks to determine whether IVR can enhance therapy outcomes by improving engagement, attention, and vocal control in individuals undergoing voice therapy, potentially maximizing treatment gains. Through this research, the aim is to assess the efficacy of IVR in enhancing voice therapy interventions and addressing the unique challenges posed by stress and anxiety in voice users.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Voice Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Meditation with VR

Those who receive meditation in immersive virtual reality prior to voice therapy each of the 4 sessions.

Group Type EXPERIMENTAL

Voice therapy

Intervention Type BEHAVIORAL

All patients will receive a course of voice therapy as normal.

Meditation

Intervention Type BEHAVIORAL

Meditation at the start of each session. (each session is 30 minutes)

Virtual Reality

Intervention Type DEVICE

TRIPP application in the Meta Quest 2 Virtual Reality Headset.

Meditation without VR

Those who receive meditation with verbal guidance only prior to voice therapy each of the 4 sessions.

Group Type EXPERIMENTAL

Voice therapy

Intervention Type BEHAVIORAL

All patients will receive a course of voice therapy as normal.

Meditation

Intervention Type BEHAVIORAL

Meditation at the start of each session. (each session is 30 minutes)

No Meditation

Those who receive standard voice therapy with no meditation.

Group Type SHAM_COMPARATOR

Voice therapy

Intervention Type BEHAVIORAL

All patients will receive a course of voice therapy as normal.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Voice therapy

All patients will receive a course of voice therapy as normal.

Intervention Type BEHAVIORAL

Meditation

Meditation at the start of each session. (each session is 30 minutes)

Intervention Type BEHAVIORAL

Virtual Reality

TRIPP application in the Meta Quest 2 Virtual Reality Headset.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with voice disorders, difficulties or laryngeal hypersensitivity, and who also have anxiety
* Must have availability to participate for entire course of 5 consistent weeks

* Presence of any additional medical condition significantly affecting:

* Respiratory function (e.g., advanced lung disease)
* Laryngeal function (e.g., status-post deep brain stimulation)
* Lingual function
* Velopharyngeal function (e.g., laryngectomy)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Icahn School of Medicine at Mount Sinai

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bradley Hoff

Speech-Language Pathologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bradley R Hoff, MA, CCC-SLP

Role: PRINCIPAL_INVESTIGATOR

Icahn School of Medicine at Mount Sinai, Department of Otolaryngology

Ümit Daşdöğen, Ph.D., CCC-SLP

Role: STUDY_DIRECTOR

Icahn School of Medicine at Mount Sinai, Department of Otolaryngology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mount Sinai Downtown Union Square

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY-24-01217

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

VR AI Meditation for Pain
NCT07122843 RECRUITING NA